Results 261 to 270 of about 201,172 (306)

Effects of a pain oriented biobehavioral therapeutic education program on brain plasticity and pain intensity in subjects with chronic musculoskeletal pain: a feasibility study of a randomized controlled trial. [PDF]

open access: yesFront Neurosci
Di-Bonaventura S   +11 more
europepmc   +1 more source

Genetic engineering of gut commensals: heterologous protein expression in <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> CECT8145. [PDF]

open access: yesCurr Res Microb Sci
Arévalo-Lalanne A   +5 more
europepmc   +1 more source

Parâmetros de flexibilidade e impulsão vertical em atletas de futebol da categoria sub 20

open access: yesRevista Brasileira de Futsal e Futebol, 2012
Carlos André Salvadeo Júnior   +5 more
doaj  

Confirmatory factor analysis of the internet addiction test in university students. [PDF]

open access: yesRev Cuid
Coelho MMF   +10 more
europepmc   +1 more source

DERMACLEAR: AI‐Powered Insights Into Four Chronic Inflammatory Skin Diseases in Spain

open access: yesJEADV Clinical Practice, EarlyView.
Using an AI‐enhanced analysis of electronic health records from nearly 50,000 patients, the DERMACLEAR study provides real‐world insights into the prevalence, clinical complexity, comorbidities and treatment patterns of HS, CU, PsO and AD in Spain.
Ana Giménez‐Arnau   +11 more
wiley   +1 more source

Muscle Activation Differences Between CKCUEST and Modified CKCUEST: A Pilot Study. [PDF]

open access: yesHealthcare (Basel)
Gutiérrez-Torre SE   +3 more
europepmc   +1 more source

Nephrogenic Systemic Fibrosis: A Rare Contemporary Case After a Decade of Declining Incidence

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Nephrogenic systemic fibrosis (NSF) is a rare fibrosing disorder associated with exposure to gadolinium‐based contrast agents in patients with renal impairment. Although its incidence has markedly declined since the restriction of high‐risk linear gadolinium agents, sporadic cases may still occur.
Marta Sánchez Díaz   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy